MedPath

Efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomitting in patients with haematological malignancies

Not Applicable
Conditions
haematological malignancies
Registration Number
JPRN-UMIN000005733
Lead Sponsor
Tokushima University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1)hypersensitivity for palonosetron or other 5-HT3 receptor antagonist 2)wiht naisea(CTCAE Grade2) at register 3)judge to be not suitable by the attending physycian

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath